Healthcare Global Enterprises

Bengaluru, Karnataka 560027

0 studies enrolling now · 2 studies all time

What they study most

Carcinoma, NSCLC, Non-Small-Cell Lung, Non-Small-Cell Lung Cancer

Studies at this site

• Lorlatinib Continuation Study — Running, not enrolling
• Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer — Completed